设为首页
收藏本站
网站地图
|
English
|
公务邮箱
About the library
Background
History
Leadership
Organization
Readers' Guide
Opening Hours
Collections
Help Via Email
Publications
Electronic Information Resources
常用资源
电子图书
期刊论文
学位会议
外文资源
特色专题
内部出版物
CNKI学位论文(537)
知网期刊论文(630)
在“
Elsevier电子期刊
”中,
命中:
261
条,耗时:小于0.01 秒
在所有数据库中总计命中:
1,167
条
1.
Cardiac safety of adjuvant non-
pegylated
liposomal
doxorubicin
combined with cyclophosphamide and followed by paclitaxel in older breast cancer patients
作者:
Luigi Coltelli
a
;
luigi.coltelli@gmail.com
;
Andrea Fontana
b
;
andrea.fontana@aruba.it
;
Sara Lucchesi
a
;
lucchesisara@libero.it
;
Laura Ginocchi
a
;
lauraginocchi@hotmail.it
;
Guido Bocci
c
;
guido.bocci@med.unipi.it
;
Mario Filidei
a
;
m.filidei@uslnordovest.toscana.it
;
Marco Scalese
d
;
scalese@ifc.cnr.it
;
Giada Arrighi
a
;
giada.arrighi@uslnordovest.toscana.it
;
Chiara Finale
a
;
chiarafinale@libero.it
;
Lorenzo Marcucci
a
;
lorenzo.marcucci@uslnordovest.toscana.it
;
Orlando Goletti
e
;
o.goletti@med.unipi.it
;
Barbara Salvadori
b
;
b.salvadori@ao-pisa.toscana.it
;
Ilaria Ferrarini
b
;
ilaria.ferrarini84@gmail.com
;
Eleonora Bona
f
;
bonaeleonora@tiscali.it
;
Alfredo Falcone
b
;
g
;
alfredo.falcone@med.unipi.it
;
Giacomo Allegrini
a
;
g.allegrini@uslnordovest.toscana.it
关键词:
Breast
;
Cancer
;
Adjuvant chemotherapy
;
Elderly
;
Non-
pegylated
;
Liposomal
;
Doxorubicin
;
Cyclophosphamide
;
Paclitaxel
刊名:The Breast
出版年:2017
2.
ENGOT-ov-6/TRINOVA-2: Randomised, double-blind, phase 3 study of
pegylated
liposomal
doxorubicin
plus trebananib or placebo in women with recurrent partially platinum-sensitive or resistant ovarian cancer
作者:
Christian Marth
a
;
Christian.MARTH@tirol-kliniken.at
;
Ignace Vergote
b
;
Giovanni Scambia
c
;
Willi Oberaigner
d
;
Andrew Clamp
e
;
Regina Berger
a
;
Christian Kurzeder
f
;
Nicoletta Colombo
g
;
Peter Vuylsteke
h
;
Domenica Lorusso
i
;
Marcia Hall
j
;
Vincent Renard
k
;
Sandro Pignata
l
;
Rebecca Kristeleit
m
;
Sevilay Altintas
n
;
Gordon Rustin
j
;
Robert M. Wenham
o
;
Mansoor Raza Mirza
p
;
Peter C. Fong
q
;
Amit Oza
r
;
Bradley J. Monk
s
;
Haijun Ma
t
;
Florian D. Vogl
t
;
Bruce A. Bach
t
关键词:
ENGOT-ov-6/TRINOVA-2
;
Trebananib
;
Pegylated
liposomal
doxorubicin
;
Progression-free survival
;
Objective response rate
;
Duration of response
刊名:European Journal of Cancer
出版年:2017
3.
Fabrication of
liposomal
doxorubicin
exhibiting ultrasensitivity against phospholipase A
2
for efficient pulmonary drug delivery to lung cancers
作者:
Tatsuaki Tagami
;
Yuta Ando
;
Tetsuya Ozeki
;
ozekit@phar.nagoya-cu.ac.jp
关键词:
Liposome
;
Phospholipase A2
;
Inhalation formulation
;
Poloxamer
;
Triggered release
;
Lung cancer
刊名:International Journal of Pharmaceutics
出版年:2017
4.
The role of the ATM/Chk/P53 pathway in mediating DNA damage in hand-foot syndrome induced by PLD
作者:
Jie Yang
1
;
Long Qiao
1
;
Zhen Zeng
;
Junnai Wang
;
Tao Zhu
;
Juncheng Wei
;
Mingfu Wu
;
Shuangmei Ye
;
Xiaoyuan Huang
;
Ding Ma
;
Ronghua Liu
;
liuzhu38@126.com
;
Qinglei Gao
;
qlgao@tjh.tjmu.edu.cn
关键词:
Pegylated
liposomal
doxorubicin
(PLD)
;
HaCaT cell
;
Apoptosis
;
Zebrafish
刊名:Toxicology Letters
出版年:2017
5.
Pulsed-wave low-dose ultrasound hyperthermia selectively enhances nanodrug delivery and improves antitumor efficacy for brain metastasis of breast cancer
作者:
Sheng-Kai Wu
a
;
Chi-Feng Chiang
a
;
Yu-Hone Hsu
a
;
d
;
Houng-Chi Liou
b
;
Wen-Mei Fu
b
;
Win-Li Lin
a
;
c
;
winli@ntu.edu.tw
关键词:
Pulsed-wave
;
Low-dose
;
Ultrasound hyperthermia
;
Nanodrug
;
Brain tumors
刊名:Ultrasonics Sonochemistry
出版年:2017
6.
Biweekly
Pegylated
Liposomal
Doxorubicin
(Caelyx) in Heavily Pretreated Metastatic Breast Cancer: A Phase 2 Study
作者:
Christian F. Jehn
1
;
Christian.Jehn@charite.de" class="auth_mail" title="E-mail the corresponding author
;
Philipp Hemmati
1
;
Silvia Lehenbauer-Dehm
1
;
Sherko Kü
;
mmel
2
;
Bernd Flath
3
;
Peter Schmid
4
关键词:
Advanced breast cancer
;
Anthracyclines
;
Pegylated
liposomal
doxorubicin
(PLD)
;
Phase II Trial
刊名:Clinical Breast Cancer
出版年:2016
7.
Phase 1b safety study of farletuzumab, carboplatin and
pegylated
liposomal
doxorubicin
in patients with platinum-sensitive epithelial ovarian cancer
作者:
Kenneth H. Kim
a
;
Danijela Jelovac
b
;
Deborah K. Armstrong
b
;
Benjamin Schwartz
c
;
Susan C. Weil
d
;
Charles Schweizer
d
;
Ronald D. Alvarez
e
;
ralvarez@uabmc.edu" class="auth_mail" title="E-mail the corresponding author
关键词:
Ovarian cancer
;
Platinum-sensitive relapse
;
Pegylated
liposomal
doxorubicin
;
Farletuzumab
;
Monoclonal antibody therapy
刊名:Gynecologic Oncology
出版年:2016
8.
Improvement in the drug delivery and anti-tumor efficacy of
PEGylated
liposomal
doxorubicin
by targeting RNA aptamers in mice bearing breast tumor model
作者:
Seyedeh Alia Moosavian
a
;
Khalil Abnous
b
;
abnouskh@mums.ac.ir" class="auth_mail" title="E-mail the corresponding author
;
Ali Badiee
c
;
Mahmoud Reza Jaafari
a
;
jafarimr@mums.ac.ir" class="auth_mail" title="E-mail the corresponding author
关键词:
Aptamer
;
Cancer targeting
;
PEGylated
-
liposomal
doxorubicin
;
Breast cancer
刊名:Colloids and Surfaces B: Biointerfaces
出版年:2016
9.
Using solution X-ray scattering to determine the high-resolution structure and morphology of
PEGylated
liposomal
doxorubicin
nanodrugs
作者:
Y. Schilt
a
;
c
;
T. Berman
b
;
c
;
X. Wei
b
;
1
;
Y. Barenholz
b
;
c
;
chezyb@gmail.com" class="auth_mail" title="E-mail the corresponding author
;
U. Raviv
a
;
c
;
uri.raviv@mail.huji.ac.il" class="auth_mail" title="E-mail the corresponding author
关键词:
EPR
;
Enhanced permeability and retention
;
PLD
;
PEGylated
liposomal
doxorubicin
;
FDA
;
Food and Drug Administration
;
EMA
;
European Medicines Agency
刊名:Biochimica et Biophysica Acta (BBA) - General Subjects
出版年:2016
10.
A comparison of overall survival with 40 and 50 mg/m
2
pegylated
liposomal
doxorubicin
treatment in patients with recurrent epithelial ovarian cancer: Propensity score-matched analysis of real-world data
作者:
Masahiko Nakayama
;
mnakayam@its.jnj.com" class="auth_mail" title="E-mail the corresponding author
;
Hisanori Kobayashi
hkobaya1@its.jnj.com" class="auth_mail" title="E-mail the corresponding author
;
Tomihiro Takahara
ttakahar@its.jnj.com" class="auth_mail" title="E-mail the corresponding author
;
Yukiko Nishimura
ynishim1@its.jnj.com" class="auth_mail" title="E-mail the corresponding author
;
Koji Fukushima
kfukush@its.jnj.com" class="auth_mail" title="E-mail the corresponding author
;
Kazutake Yoshizawa
kyoshiz1@its.jnj.com" class="auth_mail" title="E-mail the corresponding author
关键词:
Ovarian neoplasms
;
Liposomal
doxorubicin
;
Propensity score
;
Mortality
;
Hand-foot syndrome
;
Stomatitis
刊名:Gynecologic Oncology
出版年:2016
1
2
3
4
5
6
7
8
9
按检索点细分(261)
题名(160)
关键词(68)
文摘(175)
按出版年细分(261)
2027年及以后(14)
2017年(5)
2016年(26)
2015年(8)
2013年(15)
2012年(23)
2011年(24)
2010年(17)
2009年(23)
2008年(22)
2007年(11)
2006年(13)
2005年(13)
2004年(12)
2003年(14)
2002年(8)
2001年(7)
2000年(2)
2000年及以前(4)
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via
email
.